12390102

Source:http://linkedlifedata.com/resource/pubmed/id/12390102

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0002645, umls-concept:C0050940, umls-concept:C0055856, umls-concept:C0079488, umls-concept:C0378482, umls-concept:C1521828
pubmed:issue	11
pubmed:dateCreated	2002-10-22
pubmed:abstractText	The resistance of Helicobacter pylori to clarithromycin has become one of the primary reasons for eradication failure.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8707234
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/2-Pyridinylmethylsulfinylbenzimidazo..., http://linkedlifedata.com/resource/pubmed/chemical/Amoxicillin, http://linkedlifedata.com/resource/pubmed/chemical/Anti-Bacterial Agents, http://linkedlifedata.com/resource/pubmed/chemical/Anti-Ulcer Agents, http://linkedlifedata.com/resource/pubmed/chemical/Benzimidazoles, http://linkedlifedata.com/resource/pubmed/chemical/Clarithromycin, http://linkedlifedata.com/resource/pubmed/chemical/Omeprazole, http://linkedlifedata.com/resource/pubmed/chemical/Proton Pumps, http://linkedlifedata.com/resource/pubmed/chemical/lansoprazole, http://linkedlifedata.com/resource/pubmed/chemical/rabeprazole
pubmed:status	MEDLINE
pubmed:month	Nov
pubmed:issn	0269-2813
pubmed:author	pubmed-author:AbeHH, pubmed-author:AritaTT, pubmed-author:FujiokaTT, pubmed-author:KagawaJJ, pubmed-author:KodamaMM, pubmed-author:MurakamiKK, pubmed-author:NasuMM, pubmed-author:OkimotoTT, pubmed-author:SatoRR, pubmed-author:SatoSS
pubmed:issnType	Print
pubmed:volume	16
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1933-8
pubmed:dateRevised	2006-11-15
pubmed:meshHeading	pubmed-meshheading:12390102-2-Pyridinylmethylsulfinylbenzimidazoles, pubmed-meshheading:12390102-Adult, pubmed-meshheading:12390102-Amoxicillin, pubmed-meshheading:12390102-Anti-Bacterial Agents, pubmed-meshheading:12390102-Anti-Ulcer Agents, pubmed-meshheading:12390102-Benzimidazoles, pubmed-meshheading:12390102-Clarithromycin, pubmed-meshheading:12390102-Drug Resistance, Bacterial, pubmed-meshheading:12390102-Drug Therapy, Combination, pubmed-meshheading:12390102-Duodenal Ulcer, pubmed-meshheading:12390102-Female, pubmed-meshheading:12390102-Gastritis, pubmed-meshheading:12390102-Helicobacter Infections, pubmed-meshheading:12390102-Helicobacter pylori, pubmed-meshheading:12390102-Humans, pubmed-meshheading:12390102-Male, pubmed-meshheading:12390102-Middle Aged, pubmed-meshheading:12390102-Omeprazole, pubmed-meshheading:12390102-Proton Pumps, pubmed-meshheading:12390102-Stomach Ulcer
pubmed:year	2002
pubmed:articleTitle	Eradication rates of clarithromycin-resistant Helicobacter pylori using either rabeprazole or lansoprazole plus amoxicillin and clarithromycin.
pubmed:affiliation	Second Department of Internal Medicine, Oita Medical University, Oita, Japan. murakam@oita-med.ac.jp
pubmed:publicationType	Journal Article, Clinical Trial, Randomized Controlled Trial, Multicenter Study